NuLeaf Naturals, a U.S. hemp-derived CBD company owned by High Tide Inc., will participate as a supplier in the CMS Innovation Center's Beneficiary Engagement Incentive pilot program starting April 1, 2026. This program allows Medicare beneficiaries to receive eligible hemp-derived CBD products at no cost through participating healthcare organizations, aiming to integrate CBD into federally supported healthcare and gather clinical data. NuLeaf's certified products meet the program's compliance requirements, positioning the company for potential growth in the U.S. CBD market. The program may expand in 2027 to include more healthcare models, potentially boosting NuLeaf's business further.
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multi...
